Asociacion de clonixinato de lisina con ciclobenzaprina en afecciones dolorosas del raquis con contractura muscular

Prensa Medica Argentina

Volumn 85, Issue 4, 1998, Pages 507-514

  Nasswetter, Gustavo ^a,b   De Los Santos, Antonio Raul ^a,b   Marti, Manuel Luis ^a,b   Di Girolamo, Guillermo ^b  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIXIN LYSINE; CYCLOBENZAPRINE;

ADULT; AGED; ARTICLE; CERVICOBRACHIAL NEURALGIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE SPASM; SCORING SYSTEM; SYMPTOMATOLOGY;

EID: 0005061758     PISSN: 0032745X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. MOLTENI G.; DE VITO G.; GRIECO A.: Epidemiologia delle alterazioni musculo-scheletriche da sovraccarico biomeccanico (W M S D s). Med Lav 1996; 87: 469-481.
2. CONNELL M. D.; WIESEL S. W.: Natural history and pathogenesis of cervical disk disease. Orthop Clin North Am 1992; 23: 369-380.
3. VALAT J. P.; LIORET E.: Arthroses cervicales. Rev Prat 1996; 46: 2206-2211.
4. KARLBERG M.; PERSSON L.; MAGNUSSON M.: Impaired postural control in patients with cervicobrachial pain. Acta Otolaryngol Suppl (Stockh) 1995; 2: 440-442.
5. KRAPAC L.; KRMPOTIC A.; PAVICEVIC L.; DOMLJAN Z.: Cervicobrachial syndrome-work and disability. Arh Hig Rada Toksikol 1992; 43 (3): 255-262.
6. MUMENTHALER M.: Diagnose-Quiz. Ther Umsch 1993; 50 (11): 753-754.
7. RUBIO M. C.; Pharmacokinetic of Lysine clonixinate. 1st. International Conference on Pain. Buenos Aires, Argentina, 1994, April 19-20th. (Abstract 19).
8. CAYETTI L. M.; DE LOS SANTOS A. R.; MARTI M. L.; DI GIROLAMO G.; NISELMAN V.: Lysine clonixinate versus aspirin in the treatment of gonarthrosis. Curr Ther Res 1995; 56 (9): 894-905.
9. DI GIROLAMO G.; ZMIJANOVICH R.; DE LOS SANTOS A. R.; MARTI M. L.; TERRAGNO A.: Lysine clonixinate in the treatment of primary dysmenorrhea. APPTLA 1996; 46: 223-232.
10. DE LOS SANTOS A. R.; MARTI M. L.; DI GIROLAMO G.; VINACUR J. C.; CASADEI A.: Lysine Clonixinate vs. Paracetamol/Codeine in postepisiotomy pain. APPTLA 1997; 48 (1): 52-58.
11. DE LOS SANTOS A. R.; DI GIROLAMO G.; MARTI M. L.: Efficacy and tolerance of Lysine clonixinate (LC) vs Paracetamol/Codeine (PC) following inguinal hernioplasty. Int J Tiss Reac. (In Press, 1998).
12. PALLAPIES D.; MUHS A.; BERTRAM L.; ROHLEDER G. NAGYIVÁNYI P.; PESKAR B. A.: Effects of single oral doses of lysine clonixinate and a-cetylsalicylic acid on platelet functions in man. Eur J Clin Pharmacol 1996; 49: 351-354.
13. FRANCHI A. M.; DI GIROLAMO G.; DE LOS SANTOS A. R.; MARTI M. L.; GIMENO M. A. F.: Effects of Lysine clonixinate on cyclooxygenase I and II in rat lung and stomach preparations. Prostaglandins Leukot Essent Fatty Acids. (In Press, 1998).
14. FRANCHI A. M.; DI GIROLAMO G.; DE LOS SANTOS A. R.; MARTI M. L.; GIMENO M. A. F.: Efecto del Clonixinato de lisina y la Indometacina sobre la actividad de la lipooxigenasa y la ciclooxigenasa de colon humano aislado de pacientes con neoplasias. Medicina (In Press, 1998).
15. FENG L.; SUN W.; XIA Y.; TANG W. W.; CHANMIGAN P. et al: Cloning two isoforms of rat cyclooxygenase: differential regulations of their expression. Arch Biochem Biophys 1993; 307: 361-368.
16. 2 : intravenous oral and intrayeyunal administration. Gastroenterology 1976; 70: 359-370.
17. BARNES C. D.; FUNG S. J. and GINTAUTAS J.: Brainsteim noradrenergic system depression by Cyclobenzaprine. Neuropharmacology 1980; 19 (2): 221-224.
18. COMMISSIONG J. W.; KAROUM F.; REIFFENSTEIN R. J. NEFT N. H.: Cyclobenzaprine a possible mechanism of action for its muscle relaxant effect. Can J Physiol Pharmacol 1980; 59: 37-44.
19. SHARE N. N. and MCFARLANE C. S.: Cyclobenzaprine: A novel centrally acting skeletal muscle relaxant. Neuropharmacology 1975; 14: 675-684.
20. BASMAJIAN J. V.: Cyclobenzaprine hydrochloride effect on skeletal muscle spasm in the lumbar region and neck: Two double-blind controlled clinical and laboratory studies. Arch Phys Med Rehabil 1978; 59: 58-63.
21. Nibbelink D. W.; STRICKLAND S. C.; McLEAN L. F. et al: Cyclobenzaprine. diazepam and placebo in the treatment of skeletal muscle spasm of local origin. Clin Ther 1978; 1 (6): 409-424.
22. ROLLINGS H. E.; GLASSMAN J. M. and SOYKA J. P.: Management of acute musculoskeletal conditions-thoracolumbar strain or sprain: A double-blind evaluation comparing the efficacy and safety of carisoprodol with Cyclobenzaprine hidrochioride. Curr Ther Res 1983; 34 (6): 917-928.
23. BROWN B. R. and WOMBLE J.: Cyclobenzaprine in intractable pain syndromes with muscle spasm. JAMA 1978; 240 (11): 1151-1152.
24. HUCKER H. B.; STAUFFER S. C.; ALBERT K. S. et al: Plasma levels and bioavaiiability of Cyclobenzaprine in human subjects. J Clin Pharmacol 1977; 17: 719-727.
25. HUCKER H. B.; STAUFFER S. C.: GLC determination of cyclobenzaprine in plasma and urine. J Pharm Sci 1976; 65: 1253.